Celldex Therapeutics, Inc. (CLDX)
NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
As of 09:59AM EDT. Market open.
Currency in USD
Valuation Measures4
| Market Cap (intraday) | 2.55B |
| Enterprise Value | 2.13B |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 273.46 |
| Price/Book (mrq) | 5.95 |
| Enterprise Value/Revenue | 309.65 |
| Enterprise Value/EBITDA | -15.33 |
Trading Information
Stock Price History
| Beta (5Y Monthly) | 1.56 |
| 52-Week Change 3 | 14.33% |
| S&P500 52-Week Change 3 | 23.06% |
| 52 Week High 3 | 53.18 |
| 52 Week Low 3 | 22.11 |
| 50-Day Moving Average 3 | 41.97 |
| 200-Day Moving Average 3 | 34.31 |
Share Statistics
| Avg Vol (3 month) 3 | 948.38k |
| Avg Vol (10 day) 3 | 617.54k |
| Shares Outstanding 5 | 65.7M |
| Implied Shares Outstanding 6 | 65.7M |
| Float 8 | 52.74M |
| % Held by Insiders 1 | 0.35% |
| % Held by Institutions 1 | 96.79% |
| Shares Short (Mar 28, 2024) 4 | 6.56M |
| Short Ratio (Mar 28, 2024) 4 | 5.5 |
| Short % of Float (Mar 28, 2024) 4 | 11.44% |
| Short % of Shares Outstanding (Mar 28, 2024) 4 | 9.98% |
| Shares Short (prior month Feb 29, 2024) 4 | 6.41M |
Dividends & Splits
| Forward Annual Dividend Rate 4 | N/A |
| Forward Annual Dividend Yield 4 | N/A |
| Trailing Annual Dividend Rate 3 | 0.00 |
| Trailing Annual Dividend Yield 3 | 0.00% |
| 5 Year Average Dividend Yield 4 | N/A |
| Payout Ratio 4 | 0.00% |
| Dividend Date 3 | Feb 11, 2019 |
| Ex-Dividend Date 4 | N/A |
| Last Split Factor 2 | 1:15 |
| Last Split Date 3 | Feb 11, 2019 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | Dec 31, 2023 |
| Most Recent Quarter (mrq) | Dec 31, 2023 |
Profitability
| Profit Margin | 0.00% |
| Operating Margin (ttm) | -850.33% |
Management Effectiveness
| Return on Assets (ttm) | -21.70% |
| Return on Equity (ttm) | -37.45% |
Income Statement
| Revenue (ttm) | 6.88M |
| Revenue Per Share (ttm) | 0.14 |
| Quarterly Revenue Growth (yoy) | 156.10% |
| Gross Profit (ttm) | N/A |
| EBITDA | -139.03M |
| Net Income Avi to Common (ttm) | -141.43M |
| Diluted EPS (ttm) | -2.92 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 423.6M |
| Total Cash Per Share (mrq) | 7.58 |
| Total Debt (mrq) | 2.54M |
| Total Debt/Equity (mrq) | 0.59% |
| Current Ratio (mrq) | 13.87 |
| Book Value Per Share (mrq) | 7.68 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -107.29M |
| Levered Free Cash Flow (ttm) | -46.7M |
© 2024 Yahoo. All rights reserved.